Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
146,467,184
-
Number of holders
-
648
-
Total 13F shares, excl. options
-
87,735,817
-
Shares change
-
-7,430,742
-
Total reported value, excl. options
-
$12,964,369,891
-
Value change
-
-$1,617,256,395
-
Put/Call ratio
-
73%
-
Number of buys
-
291
-
Number of sells
-
-374
-
Price
-
$147.87
Significant Holders of RESMED INC - Common Stock (RMD) as of Q3 2023
806 filings reported holding RMD - RESMED INC - Common Stock as of Q3 2023.
RESMED INC - Common Stock (RMD) has 648 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 87,735,817 shares
of 146,467,184 outstanding shares and own 60% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (17,569,822 shares), BlackRock Inc. (12,099,599 shares), STATE STREET CORP (6,163,455 shares), FMR LLC (3,811,419 shares), GEODE CAPITAL MANAGEMENT, LLC (3,388,143 shares), MORGAN STANLEY (2,329,617 shares), Invesco Ltd. (2,007,085 shares), CITADEL ADVISORS LLC (1,719,557 shares), NORTHERN TRUST CORP (1,491,269 shares), and NORGES BANK (1,302,153 shares).
This table shows the top 648 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.